Skip to content

Innoviva, Inc. INVA EPS (Diluted)

EPS (Diluted) at other companies

Pfizer logo
PfizerPFE
$0.47-9.6%
Merck & Co. logo
Merck & Co.MRK
-$1.72-186%
AbbVie logo
AbbVieABBV
$0.39-45.8%
Insmed logo
InsmedINSM
-$0.76+46.5%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-$0.56+39.8%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
-$0.96+49.5%

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%
Enterprise value$1.4B+9.7%
P/E3.5×
P/S4.1×+1.0×

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s EPS (diluted)?
Innoviva, Inc. (INVA) reported EPS (diluted) of $2.22 in Q1 2026.
How has Innoviva, Inc.'s EPS (diluted) changed year-over-year?
Innoviva, Inc.'s EPS (diluted) increased by 400.0% year-over-year, from -$0.74 to $2.22.
What is the long-term trend for Innoviva, Inc.'s EPS (diluted)?
Over 3 years (2021 to 2025), Innoviva, Inc.'s EPS (diluted) has grown at a 2.0% compound annual growth rate (CAGR), from $2.88 to $3.06.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.